Markus Mueller

545 total citations
26 papers, 299 citations indexed

About

Markus Mueller is a scholar working on Infectious Diseases, Oncology and Molecular Biology. According to data from OpenAlex, Markus Mueller has authored 26 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Markus Mueller's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Markus Mueller is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Markus Mueller collaborates with scholars based in Germany, United States and Switzerland. Markus Mueller's co-authors include S. Sperl, Colin Borland, Burkhard Manfras, Peter Kern, Luis Moroder, Georg Haerter, Viktor Magdolen, Carsten A. Wagner, Philipp Kirchhoff and Christine Remy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Carcinogenesis.

In The Last Decade

Markus Mueller

23 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Mueller Germany 11 85 56 48 44 44 26 299
Irene Fernández Spain 12 167 2.0× 68 1.2× 23 0.5× 66 1.5× 28 0.6× 25 352
A Prentice United Kingdom 2 84 1.0× 92 1.6× 20 0.4× 21 0.5× 38 0.9× 2 372
Dajiang Li China 12 130 1.5× 62 1.1× 93 1.9× 64 1.5× 63 1.4× 23 365
Dennis L. Cook United States 9 230 2.7× 74 1.3× 59 1.2× 43 1.0× 51 1.2× 11 456
Sayonara M. Viana Brazil 6 91 1.1× 113 2.0× 49 1.0× 8 0.2× 50 1.1× 12 407
Yajing Gao United States 15 194 2.3× 79 1.4× 86 1.8× 33 0.8× 154 3.5× 32 577
Amit Aggarwal India 12 118 1.4× 81 1.4× 64 1.3× 9 0.2× 21 0.5× 23 391
Salomè V. Ibba United States 11 98 1.2× 61 1.1× 114 2.4× 38 0.9× 124 2.8× 20 360
Kamlendra Singh United States 8 140 1.6× 164 2.9× 72 1.5× 148 3.4× 18 0.4× 11 444
Lina Panayiota Aristoteli Australia 8 162 1.9× 20 0.4× 15 0.3× 15 0.3× 72 1.6× 9 352

Countries citing papers authored by Markus Mueller

Since Specialization
Citations

This map shows the geographic impact of Markus Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Mueller more than expected).

Fields of papers citing papers by Markus Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Mueller. The network helps show where Markus Mueller may publish in the future.

Co-authorship network of co-authors of Markus Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Mueller. A scholar is included among the top collaborators of Markus Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Mueller. Markus Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Budde, Katharina B., et al.. (2024). Genetic variation of English yew (Taxus baccata L.) in the Bavarian Forest National Park, Germany. European Journal of Forest Research. 143(4). 1249–1265. 2 indexed citations
3.
Bokemeyer, Bernd, Tibor Hlavatý, Matthieu Allez, et al.. (2023). Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD). Expert Opinion on Biological Therapy. 23(8). 791–800. 4 indexed citations
4.
Budde, Katharina B., et al.. (2022). Genetic diversity and fine-scale spatial genetic structure of the near-threatened Pinus gerardiana in Gardiz, Afghanistan. Plant Ecology and Evolution. 155(3). 363–378. 4 indexed citations
5.
Grillari, Johannes, et al.. (2022). High cysteine concentrations in cell culture media lead to oxidative stress and reduced bioprocess performance of recombinant CHO cells. Biotechnology Journal. 17(11). e2200029–e2200029. 16 indexed citations
6.
Mysler, Eduardo, Valderílio Feijó Azevedo, Silvio Danese, et al.. (2021). Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?. Drugs. 81(16). 1859–1879. 28 indexed citations
7.
Wiehle, Martin, Iftikhar Alam, Asif Ali Khan, et al.. (2021). Pheno-genetic studies of apple varieties in northern Pakistan: A hidden pool of diversity. Scientia Horticulturae. 281. 109950–109950. 4 indexed citations
8.
Bickel, Markus, Christian Hoffmann, Eva Wolf, et al.. (2020). High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection. 48(3). 453–461. 10 indexed citations
9.
Mueller, Markus, et al.. (2019). Genetic diversity of common guava in Kenya: an underutilized naturalized fruit species. Fruits. 74(5). 236–248. 5 indexed citations
10.
Krutovsky, Konstantin V., Markus Mueller, Oliver Gailing, et al.. (2018). Morphological and Genetic Diversity of Sea Buckthorn (Hippophae rhamnoides L.) in the Karakoram Mountains of Northern Pakistan. Diversity. 10(3). 76–76. 10 indexed citations
11.
Hentrich, Marcus, Christoph Wyen, Daniel Gillor, et al.. (2016). Lymphoma-associated mortality in the German HIV-lymphoma cohort study.. Journal of Clinical Oncology. 34(15_suppl). 7550–7550.
12.
Stocker, Hartmut, et al.. (2011). Treatment of HIV-related primary central nervous system lymphoma with azt high dose, HAART, interleukin-2 and foscarnet in three patients. European journal of medical research. 16(5). 197–197. 4 indexed citations
13.
Stephan, Christoph, H. Jaeger, Gaby Knecht, et al.. (2010). Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients. European journal of medical research. 15(9). 369–369. 1 indexed citations
14.
Genton, Blaise, Gerd Pluschke, Lukas Degen, et al.. (2007). A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers. PLoS ONE. 2(10). e1018–e1018. 44 indexed citations
15.
Remy, Christine, Philipp Kirchhoff, Patricia Hafner, et al.. (2007). Stimulatory Pathways of the Calcium-Sensing Receptor on Acid Secretion in Freshly Isolated Human Gastric Glands. Cellular Physiology and Biochemistry. 19(1-4). 33–42. 37 indexed citations
16.
Mirancea, Nicolae, Silvia Vosseler, Alessandra Pavesio, et al.. (2006). Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis. 28(3). 595–610. 24 indexed citations
17.
Haerter, Georg, et al.. (2004). Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir. AIDS. 18(6). 952–955. 31 indexed citations
18.
Mueller, Markus, S. Sperl, Jörg Stürzebecher, Wolfram Bode, & Luis Moroder. (2002). (R)-3-Amidinophenylalanine-Derived Inhibitors of Factor Xa with a Novel Active-Site Binding Mode. Biological Chemistry. 383(7-8). 1185–91. 11 indexed citations
19.
Sperl, S., Markus Mueller, Olaf G. Wilhelm, et al.. (2001). The uPA/uPA receptor system as a target for tumor therapy. Drug News & Perspectives. 14(7). 401–401. 21 indexed citations
20.
Mueller, Markus & Colin Borland. (1997). Delayed cyanide poisoning following acetonitrile ingestion. Postgraduate Medical Journal. 73(859). 299–300. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026